UAE (United Arab Emirates) blood transfusion and screening procedures improve
This article was originally published in Clinica
The UAE is to improve its blood transfusion services by extending the use of technology for removing leukocyte from blood by filtration. The ministry of health previously only allowed the process, known as leukodepletion, to be used in critical procedures such as dialysis and cases of patients with immune deficiencies. Dr Abdul Raheem Jaffar, under-secretary at the health ministry, told the Khaleej Times that the government's decision to extend leukodepletion, for which it spends Dh20 million ($5.4 million) a year was aimed at guaranteeing the safety of patients. He added that due to the strict criteria of donor selection, blood transfusion in the UAE was now 100% safe.